Cargando…

A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer

We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjerkli, Inger-Heidi, Hadler-Olsen, Elin, Nginamau, Elisabeth Sivy, Laurvik, Helene, Søland, Tine M., Costea, Daniela Elena, Uhlin-Hansen, Lars, Steigen, Sonja E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683438/
https://www.ncbi.nlm.nih.gov/pubmed/32607687
http://dx.doi.org/10.1007/s00428-020-02875-9
_version_ 1783612877604651008
author Bjerkli, Inger-Heidi
Hadler-Olsen, Elin
Nginamau, Elisabeth Sivy
Laurvik, Helene
Søland, Tine M.
Costea, Daniela Elena
Uhlin-Hansen, Lars
Steigen, Sonja E.
author_facet Bjerkli, Inger-Heidi
Hadler-Olsen, Elin
Nginamau, Elisabeth Sivy
Laurvik, Helene
Søland, Tine M.
Costea, Daniela Elena
Uhlin-Hansen, Lars
Steigen, Sonja E.
author_sort Bjerkli, Inger-Heidi
collection PubMed
description We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00428-020-02875-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7683438
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-76834382020-11-30 A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer Bjerkli, Inger-Heidi Hadler-Olsen, Elin Nginamau, Elisabeth Sivy Laurvik, Helene Søland, Tine M. Costea, Daniela Elena Uhlin-Hansen, Lars Steigen, Sonja E. Virchows Arch Original Article We wanted to evaluate the prognostic value of common histopathological variables in a large cohort of patients with cancer in the mobile tongue as such information can be important for treatment stratification of the individual patient, especially for patients with low-stage disease. In addition, we wanted to investigate whether an alternative scoring model with fewer options would compromise the prognostic value. One hundred fifty patients with oral tongue squamous cell carcinomas that were treated in curative intent and with available HE-stained tumor sections were included. We reclassified all tumors and performed univariate and multivariate survival analyses of histopathological and clinical variables. For the complete cohort, lymph node status, grade of differentiation, perineural infiltration, and lymphocytic infiltration were independent prognosticators. In the low-stage disease group, independent prognostic factors were tumor size, grade of differentiation, and lymphocytic infiltrate. For patients with low-stage disease, a histo-score combining the scores for tumor differentiation and lymphocytic infiltrate identified a group of patients with particularly low survival, as patients with moderately or poorly differentiated tumors and little lymphocytic infiltrate had a less favorable 5-year survival outcome than patients in the high-stage disease group. This study shows that a histo-score combining tumor differentiation and lymphocytic infiltration should be given special consideration in treatment planning. Our results also illustrate that many variables can be scored with fewer options than previously suggested to increase their reproducibility, and still maintain their prognostic value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00428-020-02875-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-30 2020 /pmc/articles/PMC7683438/ /pubmed/32607687 http://dx.doi.org/10.1007/s00428-020-02875-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Bjerkli, Inger-Heidi
Hadler-Olsen, Elin
Nginamau, Elisabeth Sivy
Laurvik, Helene
Søland, Tine M.
Costea, Daniela Elena
Uhlin-Hansen, Lars
Steigen, Sonja E.
A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
title A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
title_full A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
title_fullStr A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
title_full_unstemmed A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
title_short A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
title_sort combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683438/
https://www.ncbi.nlm.nih.gov/pubmed/32607687
http://dx.doi.org/10.1007/s00428-020-02875-9
work_keys_str_mv AT bjerkliingerheidi acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT hadlerolsenelin acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT nginamauelisabethsivy acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT laurvikhelene acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT sølandtinem acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT costeadanielaelena acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT uhlinhansenlars acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT steigensonjae acombinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT bjerkliingerheidi combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT hadlerolsenelin combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT nginamauelisabethsivy combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT laurvikhelene combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT sølandtinem combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT costeadanielaelena combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT uhlinhansenlars combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer
AT steigensonjae combinedhistoscorebasedontumordifferentiationandlymphocyticinfiltrateisarobustprognosticmarkerformobiletonguecancer